APA (7th ed.) Citation

JW, L., JS, A., PA, B., D, B., K, C., KW, D., . . . NA, F. (2021). Discovery of a First-in-Class Inhibitor of the Histone Methyltransferase SETD2 Suitable for Preclinical Studies. ACS medicinal chemistry letters, 12(10), 1539. https://doi.org/10.1021/acsmedchemlett.1c00272

Chicago Style (17th ed.) Citation

JW, Lampe, et al. "Discovery of a First-in-Class Inhibitor of the Histone Methyltransferase SETD2 Suitable for Preclinical Studies." ACS Medicinal Chemistry Letters 12, no. 10 (2021): 1539. https://doi.org/10.1021/acsmedchemlett.1c00272.

MLA (9th ed.) Citation

JW, Lampe, et al. "Discovery of a First-in-Class Inhibitor of the Histone Methyltransferase SETD2 Suitable for Preclinical Studies." ACS Medicinal Chemistry Letters, vol. 12, no. 10, 2021, p. 1539, https://doi.org/10.1021/acsmedchemlett.1c00272.